Summit Securities Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24
| Closed | -$3.67K | – | 669 |
|
|
2024
Q4 | $3.67K | Sell |
24
-476
| -95% | -$72.8K | ﹤0.01% | 407 |
|
|
2024
Q3 | $97K | Buy |
500
+481
| +2,532% | +$93.3K | 0.03% | 97 |
|
|
2024
Q2 | $4K | Sell |
19
-781
| -98% | -$164K | ﹤0.01% | 382 |
|
|
2024
Q1 | $173K | Sell |
800
-112
| -12% | -$24.2K | 0.03% | 76 |
|
|
2023
Q4 | $236K | Buy |
912
+896
| +5,600% | +$232K | 0.02% | 108 |
|
|
2023
Q3 | $4K | Sell |
16
-32
| -67% | -$8K | ﹤0.01% | 315 |
|
|
2023
Q2 | $14K | Buy |
+48
| New | +$14K | ﹤0.01% | 588 |
|
|
2022
Q4 | – | Sell |
-571
| Closed | -$152K | – | 914 |
|
|
2022
Q3 | $152K | Buy |
+571
| New | +$152K | 0.01% | 300 |
|
|
2022
Q2 | – | Sell |
-664
| Closed | -$140K | – | 731 |
|
|
2022
Q1 | $140K | Buy |
+664
| New | +$140K | 0.02% | 285 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 378 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 165 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 150 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 133 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 213 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 146 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 115 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 146 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 129 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 91 |
|
|
2016
Q3 | – | Sell |
-6,363
| Closed | -$1.54M | – | 126 |
|
|
2016
Q2 | $1.54M | Sell |
6,363
-215
| -3% | -$52K | 0.82% | 26 |
|
|
2016
Q1 | $1.71M | Buy |
+6,578
| New | +$1.71M | 1.2% | 18 |
|